Eureka Institute for Translational Medicine

What Eureka Institute for Translational Medicine does

Eureka Institute for Translational Medicine is a not-for-profit educational organization incorporated in Italy in 2008 by Prof. Berent Prakken and Prof. Salvatore Albani. It operates three flagship programs — the two-year Master of Translational Medicine delivered in partnership with Duke-NUS Medical School (Singapore) and Università Vita-Salute San Raffaele (Italy), the one-week International Certificate Course in Siracusa, Italy, and Seasonal Schools in Singapore and Utrecht, The Netherlands. These programs target mid-career clinicians, scientists, industry professionals, patient organisations, and academic leaders seeking training in translational medicine leadership, defined by the institute as operating in the "fragile middle" between scientific discovery and healthcare delivery.

The institute does not develop proprietary technology products; instead, it is a curriculum-and-community franchise built on experiential learning models with faculty drawn from leading global institutions. Applications and degree credentials are routed through partner university admissions portals. Co-founder Prof. Salvatore Albani separately leads AI-driven immunology research at the Translational Immunology Institute (Singapore Health Services / Duke-NUS), where he holds over 100 patents, but this research activity sits in an affiliated institute rather than in Eureka's core educational operations.

Eureka generates revenue primarily through program tuition fees, classified as professional-services revenue. Pricing is not publicly disclosed and is delegated to partner institution pages. The institute operates with a small core team of approximately 7 employees and is governed by a Board of Directors, with Charles B. Cairns as Chairman. Its network encompasses 1,400+ alumni ("Eurekians") across at least four countries and 258 named contributors spanning academia, healthcare, regulation, industry, and investment, positioning the institute as a community-led rather than commercially scaled operator.

Name

Eureka Institute for Translational Medicine

Legal name

Eureka Institute for Translational Medicine

Website

https://eurekainstitute.org

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Eureka Institute for Translational Medicine is a not-for-profit educational organization founded in 2008 that delivers translational medicine leadership programs — a Master's, a Certificate Course, and Seasonal Schools — to mid-career clinicians, scientists, industry professionals, and patient organisations through partnerships with Duke-NUS, Università Vita-Salute San Raffaele, and Utrecht University.

Ownership category

akta.pro rank

Product category

Medical Education and Training

NAICS

Colleges, Universities, and Professional Schools (611310), Educational Support Services (611710)

SIC

Services-Educational Services (8200)

akta.pro industry

PRIMARYEDAIAJAF

Integrated Language + Academic Skills (EAP) Bridging Programs

Education/International Education & Study Abroad/Overseas Pathway, Foundation & Bridging Programs

Keywords

• Translational medicine education
• Medical leadership training
• Experiential learning programs
• Healthcare professional development
• Executive medical programs

Headquarters

HQ city

Siracusa

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Educational Programs: Eureka generates revenue through its flagship educational programs including the Master of Translational Medicine (delivered in partnership with Duke-NUS and Università Vita-Salute San Raffaele), International Certificate Course in Siracusa, Italy, and Seasonal Schools in Singapore and Utrecht. Programs target mid-career professionals, clinicians, scientists, and industry leaders seeking translational medicine expertise.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Eureka Institute for Translational Medicine delivers experiential educational programs that develop translational leadership and fluency for healthcare and scientific professionals. Its portfolio spans the two-year Master of Translational Medicine (delivered in partnership with Duke-NUS in Singapore and Università Vita-Salute San Raffaele in Milan), the one-week International Certificate Course in Siracusa, Italy, and Seasonal Schools in Singapore and Utrecht. Participants engage with faculty and mentors from leading academic institutions across science, medicine, regulation, industry, and investment to navigate the full continuum from discovery to patient benefit.

Product overview

Eureka Institute for Translational Medicine offers a platform of experiential educational programs in translational medicine leadership. The portfolio includes three flagship programs: the two-year Master of Translational Medicine (delivered at Duke-NUS in Singapore and Università Vita-Salute San Raffaele in Milan), the one-week International Certificate Course in Siracusa, Italy, and the Seasonal Schools program with regional hubs in Singapore and Utrecht. These programs work together as a progressive ecosystem—Seasonal Schools serve as an entry point, the International Certificate Course provides intensive mid-career training, and the Master's program offers deep, comprehensive leadership development—all unified by Eureka's global network and experiential learning philosophy.

Differentiator

Problem solved

Functional benefit

Products and services

• Master of Translational Medicine
• International Certificate Course
• Seasonal Schools

Quantifiable outcome

• 1,400+ Eurekians worldwide have completed programs and joined the global translational medicine community
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and strategic.

• Duke-NUS Medical SchoolcoreStrategic or Co-development PartnerStrategic partnership for delivery of the Master of International Translational Medicine program. Professor Scott Allen Compton serves as Senior Associate Dean for Medical Education at Duke-NUS and co-created the Master of International Translational Medicine program by Eureka. The program is located at Duke-NUS in Singapore.
• Università Vita-Salute San RaffaelecoreStrategic or Co-development PartnerPartnership for delivery of the Master of Translational Medicine program at the Milan, Italy campus. The program is open for applications with November 2026 intake.
• Utrecht University / Utrecht Medical CentercoreStrategic or Co-development PartnerLong-standing partnership for the International Summer School Seasonal School program and collaborative educational initiatives. Professor Berent Prakken, Co-Founder and CEO, has served as Vice-Dean and Director of the Biomedical Education Center at UMCU.
• Translational Immunology Institute (Singapore Health Services / Duke-NUS)coreStrategic or Co-development PartnerProfessor Salvatore Albani, Co-Founder and President, serves as Founder and Director of the Translational Immunology Institute at Singapore Health Services and Duke-NUS Medical School, where he pioneered AI-driven immunology research.
• Canadian Institutes of Health Research (CIHR)coreStrategic or Co-development PartnerProfessor Norman Rosenblum, Board Member, serves as Scientific Director of CIHR Institute of Nutrition, Metabolism and Diabetes. CIHR is Canada's federal health research investment agency leading national research priorities.
• Drexel UniversitystrategicStrategic or Co-development PartnerDr. Charles B. Cairns, Chairman of Eureka, serves as Walter H. and Leonore Annenberg Dean of the College of Medicine and Senior Vice President for Medical Affairs at Drexel University, shaping academic medicine through institutional transformation and health system innovation.
• University of Toronto / SickKidsstrategicStrategic or Co-development PartnerProfessor Norman Rosenblum serves as Professor of Paediatrics, Physiology, and Laboratory Medicine at the University of Toronto and Senior Scientist at SickKids (The Hospital for Sick Children), advancing molecular understanding of kidney development.
• Pediatric Rheumatology European Society (PRES)strategicOthersProfessor Berent Prakken served as President of PRES, contributing to European and global rheumatology networks and advancing international collaboration in pediatric immunology research.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Harvard Catalyst | The Harvard Clinical and Translational Science Center: University-hosted translational research training and education center providing certificate, postgraduate, and career development programs. Competes for the same mid-career clinician-scientist and translational researcher audience with deeper institutional resources.
• Duke Clinical Research Institute (DCRI): Academic clinical research organization offering research training and education programs for clinicians, scientists, and industry professionals. Shares target audience and translational/clinical research focus with Eureka's Master's curriculum.
• Stanford Center for Clinical and Translational Science and Education (Spectrum): Stanford's translational science institute offering KL2 training, master's, and certificate programs in translational research. Comparable in target persona and program format, with substantially larger institutional backing.

Emerging players

• Translational Medicine @ Oxford (University of Oxford): University of Oxford's translational medicine MSc and doctoral training initiatives targeting the same early-to-mid-career clinician-scientist persona. Comparable academic credential, backed by a tier-1 university.
• European Molecular Biology Laboratory (EMBL) Training Programmes: Intergovernmental research organization's training programs in molecular life sciences and translational research. Competes for the same early-career European biomedical researcher audience with strong brand recognition.

Direct peers

• Drug Information Association (DIA): Global professional association offering training, certificate programs, and conferences in pharmaceutical R&D, translational science, and regulatory affairs. Directly comparable in serving mid-career pharma/biotech professionals with executive-style training formats.
• European Centre of Pharmaceutical Medicine (ECPM): Switzerland-based training center offering postgraduate diploma and certificate programs in pharmaceutical medicine and translational development. Directly comparable in delivering executive-style translational training to mid-career professionals.
• European Society for Translational Medicine (EUSTM): Professional society dedicated to advancing translational medicine across Europe through education, conferences, and certification. Closest direct peer in mission of training translational researchers across sectors.

Others

• BMC Medical Education (Springer Nature): Open-access academic journal publishing medical and translational education research. Indirectly comparable as part of the translational medicine education publishing ecosystem that Eureka engages via its 'Relationship with Publishers' function.

Regional players

• Singapore A*STAR Graduate Academy: Singapore's national R&D agency training programs for biomedical and translational researchers across Asia-Pacific. Comparable to Eureka's Seasonal Schools in Singapore and overlaps in translational research curriculum.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/eureka-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eureka Institute for Translational Medicine